{"transactions":[{"id":1950156,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-03-16T16:46:11.000Z","date":"2023-03-14","kind":"tax_withholding","acquired":false,"shares":23628,"price":5.67,"value":133970.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,000 shares of the Issuer's common stock acquired by the reporting person on March 15, 2023 pursuant to an employee stock purchase program."}],"balance_after":556049,"source":{"system":"sec-edgar","filing":"0001593968-23-000491","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000159396823000491/primary_01.xml","form_type":"4"}},{"id":2016747,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-02-14T17:10:36.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":3000,"price":6.85,"value":20550.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022."}],"balance_after":577677,"source":{"system":"sec-edgar","filing":"0001593968-23-000317","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000159396823000317/primary_01.xml","form_type":"4"}},{"id":2052620,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-01-18T18:10:27.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":3000,"price":7.04,"value":21120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022."}],"balance_after":580677,"source":{"system":"sec-edgar","filing":"0001593968-23-000168","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000159396823000168/primary_01.xml","form_type":"4"}},{"id":2081822,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-12-19T16:29:07.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":5602,"price":7.5306,"value":42186.4212,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in May 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.39 to $7.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":583677,"source":{"system":"sec-edgar","filing":"0001593968-22-001742","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000159396822001742/primary_01.xml","form_type":"4"}},{"id":2317804,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-25T17:49:36.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":272435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter"}],"balance_after":272435,"derivative":{"exercise_price":9.69,"expiration_date":"2032-03-23","underlying":"Common Stock","underlying_shares":272435},"source":{"system":"sec-edgar","filing":"0001214659-22-004370","document":"marketforms-55857.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465922004370/marketforms-55857.xml","form_type":"4"}},{"id":2317803,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-25T17:49:36.000Z","date":"2022-03-23","kind":"grant","acquired":true,"shares":175438,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":589279,"source":{"system":"sec-edgar","filing":"0001214659-22-004370","document":"marketforms-55857.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465922004370/marketforms-55857.xml","form_type":"4"}},{"id":2327847,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2022-03-17T17:59:25.000Z","date":"2022-03-15","kind":"sale","acquired":false,"shares":8849,"price":7.6802,"value":67962.0898,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1021 shares of the Issuer's common stock acquired by the reporting person on March 15, 2022 pursuant to an employee stock purchase program."}],"balance_after":413841,"source":{"system":"sec-edgar","filing":"0001214659-22-004086","document":"marketforms-55822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465922004086/marketforms-55822.xml","form_type":"4"}},{"id":2566078,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-09-17T16:44:04.000Z","date":"2021-09-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":112300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-21-009625","document":"marketforms-53823.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921009625/marketforms-53823.xml","form_type":"4"}},{"id":2566077,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-09-17T16:44:04.000Z","date":"2021-09-15","kind":"sale","acquired":false,"shares":5000,"price":24.7689,"value":123844.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.64 to $24.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":421669,"source":{"system":"sec-edgar","filing":"0001214659-21-009625","document":"marketforms-53823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921009625/marketforms-53823.xml","form_type":"4"}},{"id":2566076,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-09-17T16:44:04.000Z","date":"2021-09-15","kind":"exercise","acquired":true,"shares":5000,"price":2.27,"value":11350.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 316 shares of the Issuer's common stock acquired by the reporting person on September 15, 2021 pursuant to an employee stock purchase program."}],"balance_after":426669,"source":{"system":"sec-edgar","filing":"0001214659-21-009625","document":"marketforms-53823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921009625/marketforms-53823.xml","form_type":"4"}},{"id":2600449,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-17T16:05:28.000Z","date":"2021-08-16","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":117300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-21-008761","document":"marketforms-53604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921008761/marketforms-53604.xml","form_type":"4"}},{"id":2600448,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-08-17T16:05:28.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":5000,"price":20.9988,"value":104994.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.82 to $21.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":421353,"source":{"system":"sec-edgar","filing":"0001214659-21-008761","document":"marketforms-53604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921008761/marketforms-53604.xml","form_type":"4"}},{"id":2600447,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-08-17T16:05:28.000Z","date":"2021-08-16","kind":"exercise","acquired":true,"shares":5000,"price":2.27,"value":11350.0,"ownership":{"direct":true},"balance_after":426353,"source":{"system":"sec-edgar","filing":"0001214659-21-008761","document":"marketforms-53604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921008761/marketforms-53604.xml","form_type":"4"}},{"id":2632186,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-16T16:14:53.000Z","date":"2021-07-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":122300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-21-007588","document":"marketforms-53417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921007588/marketforms-53417.xml","form_type":"4"}},{"id":2632185,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-07-16T16:14:53.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":5000,"price":21.5506,"value":107753.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.34 to $21.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":421353,"source":{"system":"sec-edgar","filing":"0001214659-21-007588","document":"marketforms-53417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921007588/marketforms-53417.xml","form_type":"4"}},{"id":2632184,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-07-16T16:14:53.000Z","date":"2021-07-15","kind":"exercise","acquired":true,"shares":5000,"price":2.27,"value":11350.0,"ownership":{"direct":true},"balance_after":426353,"source":{"system":"sec-edgar","filing":"0001214659-21-007588","document":"marketforms-53417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921007588/marketforms-53417.xml","form_type":"4"}},{"id":2666484,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T17:00:12.000Z","date":"2021-06-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":127300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-21-006631","document":"marketforms-53155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921006631/marketforms-53155.xml","form_type":"4"}},{"id":2666483,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-16T17:00:12.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":5000,"price":25.32,"value":126600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."}],"balance_after":421353,"source":{"system":"sec-edgar","filing":"0001214659-21-006631","document":"marketforms-53155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921006631/marketforms-53155.xml","form_type":"4"}},{"id":2666482,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-06-16T17:00:12.000Z","date":"2021-06-15","kind":"exercise","acquired":true,"shares":5000,"price":2.27,"value":11350.0,"ownership":{"direct":true},"balance_after":426353,"source":{"system":"sec-edgar","filing":"0001214659-21-006631","document":"marketforms-53155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921006631/marketforms-53155.xml","form_type":"4"}},{"id":2703455,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-20T17:19:43.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":132300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-21-005767","document":"marketforms-52848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921005767/marketforms-52848.xml","form_type":"4"}},{"id":2703454,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-05-20T17:19:43.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":5000,"price":30,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."}],"balance_after":421353,"source":{"system":"sec-edgar","filing":"0001214659-21-005767","document":"marketforms-52848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921005767/marketforms-52848.xml","form_type":"4"}},{"id":2703453,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-05-20T17:19:43.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":5000,"price":2.27,"value":11350.0,"ownership":{"direct":true},"balance_after":426353,"source":{"system":"sec-edgar","filing":"0001214659-21-005767","document":"marketforms-52848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921005767/marketforms-52848.xml","form_type":"4"}},{"id":2710475,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-17T17:16:08.000Z","date":"2021-05-17","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":137300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001214659-21-005621","document":"marketforms-52786.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921005621/marketforms-52786.xml","form_type":"4"}},{"id":2710474,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-05-17T17:16:08.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":5000,"price":28.2951,"value":141475.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.10 to $28.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":421353,"source":{"system":"sec-edgar","filing":"0001214659-21-005621","document":"marketforms-52786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921005621/marketforms-52786.xml","form_type":"4"}},{"id":2710473,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-05-17T17:16:08.000Z","date":"2021-05-17","kind":"exercise","acquired":true,"shares":5000,"price":2.27,"value":11350.0,"ownership":{"direct":true},"balance_after":426353,"source":{"system":"sec-edgar","filing":"0001214659-21-005621","document":"marketforms-52786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921005621/marketforms-52786.xml","form_type":"4"}},{"id":2747204,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-16T16:07:55.000Z","date":"2021-04-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":142300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001214659-21-004267","document":"marketforms-52267.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921004267/marketforms-52267.xml","form_type":"4"}},{"id":2747203,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-04-16T16:07:55.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":606,"price":32.6398,"value":19779.7188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.57 to $32.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":421353,"source":{"system":"sec-edgar","filing":"0001214659-21-004267","document":"marketforms-52267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921004267/marketforms-52267.xml","form_type":"4"}},{"id":2747202,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-04-16T16:07:55.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":9394,"price":32.0138,"value":300737.6372,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.56 to $32.54, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":421959,"source":{"system":"sec-edgar","filing":"0001214659-21-004267","document":"marketforms-52267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921004267/marketforms-52267.xml","form_type":"4"}},{"id":2747201,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-04-16T16:07:55.000Z","date":"2021-04-15","kind":"exercise","acquired":true,"shares":10000,"price":2.27,"value":22700.0,"ownership":{"direct":true},"balance_after":431353,"source":{"system":"sec-edgar","filing":"0001214659-21-004267","document":"marketforms-52267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921004267/marketforms-52267.xml","form_type":"4"}},{"id":2768173,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-30T16:55:18.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":82469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on March 13, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":82469,"derivative":{"exercise_price":33.78,"expiration_date":"2031-03-26","underlying":"Common Stock","underlying_shares":82469},"source":{"system":"sec-edgar","filing":"0001214659-21-003607","document":"marketforms-52126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921003607/marketforms-52126.xml","form_type":"4"}},{"id":2768172,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-30T16:55:18.000Z","date":"2021-03-26","kind":"grant","acquired":true,"shares":22202,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":421353,"source":{"system":"sec-edgar","filing":"0001214659-21-003607","document":"marketforms-52126.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921003607/marketforms-52126.xml","form_type":"4"}},{"id":2783014,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-17T17:00:31.000Z","date":"2021-03-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":152300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001214659-21-003242","document":"marketforms-51923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921003242/marketforms-51923.xml","form_type":"4"}},{"id":2783013,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-17T17:00:31.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":400,"price":38.15,"value":15260.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."}],"balance_after":399151,"source":{"system":"sec-edgar","filing":"0001214659-21-003242","document":"marketforms-51923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921003242/marketforms-51923.xml","form_type":"4"}},{"id":2783012,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-17T17:00:31.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":9600,"price":37.7925,"value":362808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in December 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.15 to $38.14, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":399551,"source":{"system":"sec-edgar","filing":"0001214659-21-003242","document":"marketforms-51923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921003242/marketforms-51923.xml","form_type":"4"}},{"id":2783011,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-17T17:00:31.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":6623,"price":38.1595,"value":252730.3685,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.97 to $38.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":409151,"source":{"system":"sec-edgar","filing":"0001214659-21-003242","document":"marketforms-51923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921003242/marketforms-51923.xml","form_type":"4"}},{"id":2783010,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2021-03-17T17:00:31.000Z","date":"2021-03-15","kind":"exercise","acquired":true,"shares":10000,"price":2.27,"value":22700.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 372 shares of the Issuer's common stock acquired by the reporting person on March 15, 2021 pursuant to an employee stock purchase program."}],"balance_after":415774,"source":{"system":"sec-edgar","filing":"0001214659-21-003242","document":"marketforms-51923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465921003242/marketforms-51923.xml","form_type":"4"}},{"id":2938136,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-18T16:34:04.000Z","date":"2020-12-17","kind":"exercise","acquired":false,"shares":51500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":162300,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":51500},"source":{"system":"sec-edgar","filing":"0001214659-20-010544","document":"marketforms-50661.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920010544/marketforms-50661.xml","form_type":"4"}},{"id":2938135,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-12-18T16:34:04.000Z","date":"2020-12-17","kind":"exercise","acquired":true,"shares":51500,"price":2.27,"value":116905.0,"ownership":{"direct":true},"balance_after":405402,"source":{"system":"sec-edgar","filing":"0001214659-20-010544","document":"marketforms-50661.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920010544/marketforms-50661.xml","form_type":"4"}},{"id":3010191,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-08T17:01:34.000Z","date":"2020-10-06","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":213800,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001214659-20-008504","document":"marketforms-49844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008504/marketforms-49844.xml","form_type":"4"}},{"id":3010190,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-10-08T17:01:34.000Z","date":"2020-10-06","kind":"sale","acquired":false,"shares":10000,"price":40,"value":400000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in June 2020."}],"balance_after":353902,"source":{"system":"sec-edgar","filing":"0001214659-20-008504","document":"marketforms-49844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008504/marketforms-49844.xml","form_type":"4"}},{"id":3010189,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-10-08T17:01:34.000Z","date":"2020-10-06","kind":"exercise","acquired":true,"shares":10000,"price":2.27,"value":22700.0,"ownership":{"direct":true},"balance_after":363902,"source":{"system":"sec-edgar","filing":"0001214659-20-008504","document":"marketforms-49844.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008504/marketforms-49844.xml","form_type":"4"}},{"id":3016597,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-02T16:42:31.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":223800,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-20-008378","document":"marketforms-49819.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008378/marketforms-49819.xml","form_type":"4"}},{"id":3016596,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-10-02T16:42:31.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":800,"price":37.725,"value":30180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in June 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.64 to $37.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":353902,"source":{"system":"sec-edgar","filing":"0001214659-20-008378","document":"marketforms-49819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008378/marketforms-49819.xml","form_type":"4"}},{"id":3016595,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-10-02T16:42:31.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":7985,"price":37.0274,"value":295663.789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in June 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.62 to $37.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":354702,"source":{"system":"sec-edgar","filing":"0001214659-20-008378","document":"marketforms-49819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008378/marketforms-49819.xml","form_type":"4"}},{"id":3016594,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-10-02T16:42:31.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":16215,"price":36.2053,"value":587068.9395,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in June 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.62 to $36.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":362687,"source":{"system":"sec-edgar","filing":"0001214659-20-008378","document":"marketforms-49819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008378/marketforms-49819.xml","form_type":"4"}},{"id":3016593,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-10-02T16:42:31.000Z","date":"2020-10-01","kind":"exercise","acquired":true,"shares":25000,"price":2.27,"value":56750.0,"ownership":{"direct":true},"balance_after":378902,"source":{"system":"sec-edgar","filing":"0001214659-20-008378","document":"marketforms-49819.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920008378/marketforms-49819.xml","form_type":"4"}},{"id":3039588,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-03T16:12:19.000Z","date":"2020-09-01","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":248800,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-20-007671","document":"marketforms-49584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920007671/marketforms-49584.xml","form_type":"4"}},{"id":3039587,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-09-03T16:12:19.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":400,"price":35.89,"value":14356.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2020."}],"balance_after":353902,"source":{"system":"sec-edgar","filing":"0001214659-20-007671","document":"marketforms-49584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920007671/marketforms-49584.xml","form_type":"4"}},{"id":3039586,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-09-03T16:12:19.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":24600,"price":35.35,"value":869610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.87 to $35.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":354302,"source":{"system":"sec-edgar","filing":"0001214659-20-007671","document":"marketforms-49584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920007671/marketforms-49584.xml","form_type":"4"}},{"id":3039585,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-09-03T16:12:19.000Z","date":"2020-09-01","kind":"exercise","acquired":true,"shares":25000,"price":2.27,"value":56750.0,"ownership":{"direct":true},"balance_after":378902,"source":{"system":"sec-edgar","filing":"0001214659-20-007671","document":"marketforms-49584.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920007671/marketforms-49584.xml","form_type":"4"}},{"id":3067788,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T17:09:49.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option vested on April 6, 2019, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":273800,"derivative":{"exercise_price":2.27,"expiration_date":"2028-06-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-20-006805","document":"marketforms-49403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920006805/marketforms-49403.xml","form_type":"4"}},{"id":3067787,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-08-05T17:09:49.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":16450,"price":37.2886,"value":613397.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.95 to $37.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":353902,"source":{"system":"sec-edgar","filing":"0001214659-20-006805","document":"marketforms-49403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920006805/marketforms-49403.xml","form_type":"4"}},{"id":3067786,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-08-05T17:09:49.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":15103,"price":36.4645,"value":550723.3435,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.95 to $36.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":370352,"source":{"system":"sec-edgar","filing":"0001214659-20-006805","document":"marketforms-49403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920006805/marketforms-49403.xml","form_type":"4"}},{"id":3067785,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":115481,"kind":"person","name":"Bhavnagri Veer","position":1,"cik":"0001808980","reported_name":"Bhavnagri Veer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-08-05T17:09:49.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":25000,"price":2.27,"value":56750.0,"ownership":{"direct":true},"balance_after":385455,"source":{"system":"sec-edgar","filing":"0001214659-20-006805","document":"marketforms-49403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808980/000121465920006805/marketforms-49403.xml","form_type":"4"}}]}